Our lawyers have extensive experience in the cannabis industry and stay abreast of the current legal environment and market practices.  We represent various clients in the cannabis and hemp cultivation, processing and dispensary businesses, as well as companies and institutions who are peripheral to, or investing in, the industry.  Our national and international coverage positions our lawyers to help businesses understand the complexities of this industry including how to navigate an increasingly complicated regulatory environment. We advise clients in the cannabis and hemp industry and related food and beverage industries on corporate matters, M&A, securities, licensing issues, tax, anti-money laundering, trademark disputes and clearance and litigation.

  • Represented a NYSE listed company with substantial industrial hemp division in general corporate matters.
  • Represented Cresco Labs in a reverse take-over transaction and public listing on the Canadian Stock Exchange, resulting in a public company with a market capitalization well in excess of $1 billion.
  • Represented Cresco Labs in connection with the acquisition of two regional cannabis companies in New York and Illinois.
  • Represented Cresco Labs on private international interim financing transaction (pre-reverse take-over) of approximately $100 million.
  • Represented another large multi-state cannabis operator in connection with M&A and securities matters.
  • Represented Aurora Cannabis, a Canadian licensed cannabis producer, in US securities and general corporate matters.
  • Represented Aurora Cannabis in an offering of $345 million aggregate principal amount of 5.5% convertible senior notes due 2024.
  • Represented an investment management firm on US and UK laws including criminal statutes and anti-money laundering laws in connection with proposed divestment of a portfolio company to a marijuana related business.
  • Represented a medical cannabis producer in litigation matters.
  • Advised a manufacturing company with legal issues in relation to selling products to customers in the cannabis industry.
  • Represented a university client with licensing issues related to a joint venture in the cannabis space.
  • Represented a multistate medical cannabis operator in an M&A dispute with a single-state company concerning a failed acquisition.
  • Represented a multistate medical cannabis operator in multiple disputes with investors.
  • Secured the dismissal of a proposed securities class action alleging that a multistate medical cannabis operator caused a drop in its share prices by improperly marketing products.
  • Represented several investment banks in connection with current fundraisings by US companies in the cannabis space.
  • Represented a medical cannabis industry organization with lobbying compliance, tax counseling, and other corporate matters.